FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Trifluridine Ophthalmic Solution
Status: Currently in Shortage
»Date first posted: 10/29/2019
»Therapeutic Categories: Ophthalmology

Sandoz (Reverified 01/05/2021)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Trifluridine 1% 7.5 mL (NDC 61314-044-75) Short-dated supply available; Fresh supply expected for delivery by end of October Shortage of an active ingredient

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English